<!DOCTYPE html SYSTEM "about:legacy-compat">
<html class="no-js">
  <head>
    <meta charset="utf-8"/>
    <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"/>
    <title>D.C. Law Library - D.C. Law 22-242. Behavioral Health Parity Act of 2018.</title>
    <meta property="st:title" content="D.C. Law 22-242. Behavioral Health Parity Act of 2018."/>
    <meta name="description" content="Browse the laws and code of the District of Columbia"/>
    <meta name="viewport" content="width=device-width"/>
    <link href="https://fonts.googleapis.com/css?family=Open+Sans:400italic,700italic,400,700" rel="stylesheet" type="text/css"/>
    <link rel="stylesheet" type="text/css" href="/css/main.css" media="screen"/>
    <link rel="stylesheet" type="text/css" href="/css/print.css" media="print"/>
    <script type="text/javascript">
        var _paq = _paq || [];
        _paq.push(['trackPageView']);
        _paq.push(['enableLinkTracking']);
        (function() {
            var u="//analytics.code.dccouncil.us/";
            _paq.push(['setTrackerUrl', u+'piwik.php']);
            _paq.push(['setSiteId', 1]);
            var d=document, g=d.createElement('script'), s=d.getElementsByTagName('script')[0];
            g.type='text/javascript'; g.async=true; g.defer=true; g.src=u+'piwik.js'; s.parentNode.insertBefore(g,s);
        })();
        
        window.searchHost = 'https://search.code.dccouncil.us';
        window.queryUrl = '/v1/search';
    </script>
    <noscript>
      <p>
        <img src="//analytics.code.dccouncil.us/piwik.php?idsite=1" style="border:0;" alt=""/>
      </p>
    </noscript>
  </head>
  <body>
    <header>
      <section class="container">
        <a href="http://dccouncil.us">
          <img src="/css/header_logo.png" alt="DC Seal" class="header_logo"/>
        </a>
        <h1 id="sitename">
          <a href="/dc/council/laws/22-242.html">D.C. Law 22-242. Behavioral Health Parity Act of 2018.</a>
        </h1>
        <div class="right no-print search" id="search"> </div>
      </section>
    </header>
    <main class="main container">
      <div class="clearfix" style="width: 100%;">
        <aside id="sidebar" class="col3 quiet">
          <h2>You Are Here</h2>
          <ul class="ancestors">
            <li data-search-path="library|D.C. Code" data-search-heading="D.C. Code" data-search-default="true"/>
            <li data-search-path="library" data-search-heading="All Documents">↪ <a href="/">D.C. Law Library</a></li>
            <li data-search-path="library|dclaws" data-search-heading="D.C. Laws">↪ <a href="/dclaws/">D.C. Laws Codified in the D.C. Code</a></li>
            <li data-search-path="library|dclaws|22" data-search-heading="">↪ <a href="/dclaws/22/">Council Period 22 (2017-2018)</a></li>
            <li data-search-path="library|dclaws|22|permanent" data-search-heading="">↪ <a href="/dclaws/22/permanent/">Permanent Laws</a></li>
            <li data-search-path="library|dclaws|22|permanent|D.C. Law 22-242" data-search-heading="D.C. Law 22-242">↪ D.C. Law 22-242. Behavioral Health Parity Act of 2018.</li>
          </ul>
          <div class="document-info">
            <h2>Law Information</h2>
            <dl>
              <dt>Cites</dt>
              <dd>D.C. Law 22-242 (<a class="internal-link" href="http://lims.dccouncil.us/Download/39262/B22-0597-SignedAct.pdf">PDF</a>)<br/>D.C. Act 22-568 (<a class="internal-link" href="http://lims.dccouncil.us/Download/39262/B22-0597-SignedAct.pdf">PDF</a>)<br/>66 DCR 930<br/></dd>
              <dt>Effective</dt>
              <dd>Mar. 13, 2019</dd>
              <dt>Legislative History (<a href="http://lims.dccouncil.us/Legislation/B22-0597">LIMS</a>)</dt>
              <dd>Law 22-242, the “Behavioral Health Parity Act of 2018,” was introduced in the Council and assigned Bill No. 22-597 which was referred to the Committee on Health. The bill was adopted on first and second readings on Nov. 13, 2018, and Dec. 4, 2018, respectively. After mayoral review, it was assigned Act No. 22-568 on Jan. 16, 2019, and transmitted to Congress for its review. D.C. Law 22-242 became effective Mar. 13, 2019.</dd>
            </dl>
          </div>
          <section class="cta">
            <p>
              <a href="mailto:code@dccouncil.us?subject=[ERROR]+/dc/council/laws/22-242.html">Report Error</a>
            </p>
            <p>
              <a href="mailto:code@dccouncil.us?subject=[FEEDBACK]+/dc/council/laws/22-242.html">Website Feedback</a>
            </p>
            <p>We cannot respond to questions regarding the law.</p>
          </section>
        </aside>
        <section class="col8 body">
          <h1 id="/dc/council/laws/22-242.html">D.C. Law 22-242. Behavioral Health Parity Act of 2018.</h1>
          <section class="content">
            <p style="text-align: center;">AN ACT</p>
            <p style="font-style: italic">To require health insurers offering health benefits plans in the District to comply with the requirements of the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008 and any guidance or regulations implementing the act, to require the Department of Insurance, Securities, and Banking to enforce the requirements of the act, to impose annual reporting requirements on health insurers and the department, to bar health insurers from imposing non-quantitative treatment limitations on the provision of benefits for mental health conditions or substance use disorders unless certain enumerated requirements are met, to require Medicaid to provide coverage for medication-assisted treatment prescribed for the treatment of substance use disorders, and to authorize the Mayor to issue rules to implement the provisions of the act.</p>
            <p>BE IT ENACTED BY THE COUNCIL OF THE DISTRICT OF COLUMBIA, That this act may be cited as the "Behavioral Health Parity Act of 2018".</p>
            <p class="marginalia">New <a href="/dc/council/code/titles/31/chapters/31E/">Chapter 31E of Title 31</a></p>
            <p class="marginalia">New <a href="/dc/council/code/sections/31-3175.01.html">§ 31-3175.01</a></p>
            <p id="&#xA7;2"><span class="level-num">Sec. 2. </span>Definitions.</p>
            <p>For the purposes of <code-cite doc="D.C. Code" path="31|31E">this act</code-cite>, the term:</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;2(1)">(1)</span> "Benefits" means the health care services covered by a health insurer under a health benefits plan.</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;2(2)">(2)</span> "Department" means the Department of Insurance, Securities, and Banking.</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;2(3)">(3)</span> "Health benefits plan" shall have the same meaning as provided in <code-cite doc="D.C. Code" path="&#xA7;31-3131|(4)">section 2(4) of the Prompt Pay Act of 2002, effective July 23, 2002 (D.C. Law 14-176; D.C. Official Code § 31-3131(4))</code-cite>.</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;2(4)">(4)</span> "Health insurer" shall have the same meaning as provided in <code-cite doc="D.C. Code" path="&#xA7;31-3131|(5)">section 2(5) of the Prompt Pay Act of 2002, effective July 23, 2002 (D.C. Law 14-176; D.C. Official Code § 31-3131(5))</code-cite>.</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;2(5)">(5)</span> "In-network" means providers or health care facilities that have entered into a contract or agreement with a health insurer pursuant to which such entities are obligated to provide benefits to individuals enrolled with the health insurer's health benefits plan.</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;2(6)">(6)</span> "Market conduct examination" means an examination conducted by the Department to evaluate the practices and operations of a health insurer.</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;2(7)">(7)</span> "Medicaid" means the medical assistance programs authorized by Title XIX of the Social Security Act, approved July 30, 1965 (79 Stat. 343; 42 U.S.C. § 1396 <em>et seq</em>.), and by <code-cite doc="D.C. Code" path="&#xA7;1-307.02">section 1 of An Act To enable the District of Columbia to receive Federal financial assistance under title XIX of the Social Security Act for a medical assistance program, and for other purposes, approved December 27, 1967 (81 Stat. 744; D.C. Official Code § 1-307.02)</code-cite>, and administered by the Department of Health Care Finance.</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;2(8)">(8)</span> "Medication-assisted treatment" means the use of opioid addiction treatment medication to treat substance use disorders.</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;2(9)">(9)</span> "Mental health condition" means any condition or disorder involving mental illness that falls under any of the diagnostic categories listed in the mental disorders section of the current edition of the International Classification of Diseases or that is listed in the most recent edition of the Diagnostic and Statistical Manual of Mental Disorders of the American Psychiatric Association.</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;2(10)">(10)</span> "MHPAEA" means and includes the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008, approved October 3, 2008 (Pub. L. No. 110-343; 122 Stat. 3881), and any federal guidance or regulations implementing MHPAEA, including 45 C.F.R §§ 146.136, 147.136, 147.160, and 156.115(a)(3).</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;2(11)">(11)</span> "Non-quantitative treatment limitation" means limitations imposed by a health insurer on the scope or duration of mental health condition and substance use disorder benefits for treatment, including:</p>
            <p class="text-indent-3"><span class="level-num" id="&#xA7;2(11)(A)">(A)</span> Medical management standards limiting or excluding benefits based on medical necessity, medical appropriateness, or whether the treatment is experimental or investigative;</p>
            <p class="text-indent-3"><span class="level-num" id="&#xA7;2(11)(B)">(B)</span> Formulary design for prescription drugs;</p>
            <p class="text-indent-3"><span class="level-num" id="&#xA7;2(11)(C)">(C)</span> For health benefit plans with multiple network tiers, such as preferred providers and participating providers, network tier design;</p>
            <p class="text-indent-3"><span class="level-num" id="&#xA7;2(11)(D)">(D)</span> Standards for provider admission to participate in a network, including reimbursement rates;</p>
            <p class="text-indent-3"><span class="level-num" id="&#xA7;2(11)(E)">(E)</span> Health benefits plan methods for determining usual, customary, and reasonable charges;</p>
            <p class="text-indent-3"><span class="level-num" id="&#xA7;2(11)(F)">(F)</span> Refusal to pay for higher-cost therapies until it can be shown that a lower-cost therapy is not effective, including fail-first policies or step therapy protocols;</p>
            <p class="text-indent-3"><span class="level-num" id="&#xA7;2(11)(G)">(G)</span> Exclusions based on the failure to complete a course of treatment;</p>
            <p class="text-indent-3"><span class="level-num" id="&#xA7;2(11)(H)">(H)</span> Restrictions based on geographic location, facility type, provider specialty, and other criteria that limit the scope or duration of benefits for services provided under the health benefits plan or coverage;</p>
            <p class="text-indent-3"><span class="level-num" id="&#xA7;2(11)(I)">(I)</span> In and out-of-network geographic limitations;</p>
            <p class="text-indent-3"><span class="level-num" id="&#xA7;2(11)(J)">(J)</span> Standards for providing access to out-of-network providers;</p>
            <p class="text-indent-3"><span class="level-num" id="&#xA7;2(11)(K)">(K)</span> Limitations on inpatient services for situations where the participant is a threat to self or others;</p>
            <p class="text-indent-3"><span class="level-num" id="&#xA7;2(11)(L)">(L)</span> Exclusions for court-ordered and involuntary holds;</p>
            <p class="text-indent-3"><span class="level-num" id="&#xA7;2(11)(M)">(M)</span> Experimental treatment limitations;</p>
            <p class="text-indent-3"><span class="level-num" id="&#xA7;2(11)(N)">(N)</span> Service coding;</p>
            <p class="text-indent-3"><span class="level-num" id="&#xA7;2(11)(O)">(O)</span> Exclusions for services provided by clinical social workers; and</p>
            <p class="text-indent-3"><span class="level-num" id="&#xA7;2(11)(P)">(P)</span> Network adequacy.</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;2(12)">(12)</span> "Out-of-network" means providers or health care facilities who have not entered into a contract or agreement with a health insurer pursuant to which such entities are obligated to provide benefits to individuals enrolled with the health insurer's health benefits plan.</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;2(13)">(13)</span> "Prescriber" shall have the same meaning as provided in <code-cite doc="D.C. Code" path="&#xA7;48-841.02|(3)">section 202(3) of the SafeRx Amendment Act of 2008, effective March 26, 2008 (D.C. Law 17-131; D.C. Official Code § 48-841.02(3))</code-cite>.</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;2(14)">(14)</span> "Prior authorization" means the process of obtaining prior approval from a health insurer for the provision of prescribed procedures, services, or medications.</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;2(15)">(15)</span> "Provider" shall have the same meaning as provided in <code-cite doc="D.C. Code" path="&#xA7;31-3131|(7)">section 2(7) of the Prompt Pay Act of 2002, effective July 23, 2002 (D.C. Law 14-176; D.C. Official Code § 31-3131(7))</code-cite>.</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;2(16)">(16)</span> "Step therapy" shall have the same meaning as provided in <code-cite doc="D.C. Code" path="&#xA7;48-855.01|(12)">section 2(12) of the Specialty Drug Copayment Limitation Act of 2016, effective April 7, 2017 (D.C. Law 21-248; D.C. Official Code § 48-855.01(12))</code-cite>.</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;2(17)">(17)</span> "Substance use disorder" means a problematic pattern of substance use leading to clinically significant impairment or distress, as manifested by symptoms identified in the most recent edition of the Diagnostic and Statistical Manual of Mental Disorders of the American Psychiatric Association.</p>
            <p class="marginalia">New <a href="/dc/council/code/sections/31-3175.02.html">§ 31-3175.02</a></p>
            <p id="&#xA7;3"><span class="level-num">Sec. 3. </span>Compliance and enforcement.</p>
            <p class="text-indent-1"><span class="level-num" id="&#xA7;3(a)">(a)</span> All health insurers offering health benefits plans, including Medicaid, in the District that provide mental health condition and substance use disorder benefits, shall comply with the requirements of MHPAEA.</p>
            <p class="text-indent-1"><span class="level-num" id="&#xA7;3(b)">(b)</span> The Department shall enforce the requirements of <code-cite doc="D.C. Code" path="31|31E">this act</code-cite> by:</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;3(b)(1)">(1)</span> Ensuring compliance by health insurers;</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;3(b)(2)">(2)</span> Detecting, evaluating, and responding to complaints regarding any potential or actual violations of MHPAEA;</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;3(b)(3)">(3)</span> Developing, maintaining, and regularly reviewing a publicly-available consumer complaint log recording any potential or actual violations of MHPAEA; and</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;3(b)(4)">(4)</span> Performing market conduct examinations of health insurers health benefits plans, including a review of any non-quantitative treatment limitations.</p>
            <p class="marginalia">New <a href="/dc/council/code/sections/31-3175.03.html">§ 31-3175.03</a></p>
            <p id="&#xA7;4"><span class="level-num">Sec. 4. </span>Reporting requirements.</p>
            <p class="text-indent-1"><span class="level-num" id="&#xA7;4(a)">(a)</span> Beginning October 1, 2019, and on an annual basis thereafter, health insurers shall submit a report to the Department containing the following information:</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;4(a)(1)">(1)</span><span class="level-num" id="&#xA7;4(a)(1)(A)">(A)</span> The frequency with which the health insurers health benefits plan required:</p>
            <p class="text-indent-4"><span class="level-num" id="&#xA7;4(a)(1)(A)(i)">(i)</span> Prior authorization for all prescribed procedures, services, or medications for mental health condition and substance use disorder benefits during the prior calendar year; and</p>
            <p class="text-indent-4"><span class="level-num" id="&#xA7;4(a)(1)(A)(ii)">(ii)</span> Prior authorization for all prescribed procedures, services, or medications for medical and surgical benefits during the prior calendar year.</p>
            <p class="text-indent-3"><span class="level-num" id="&#xA7;4(a)(1)(B)">(B)</span> Health insurers shall submit the information required pursuant to paragraph (1)(A) of this subsection separately for inpatient in-network benefits, inpatient out of-network benefits, outpatient in-network benefits, inpatient out-of-network benefits, outpatient in-network benefits, outpatient out-of-network benefits, emergency care benefits, and prescription drug benefits. Frequency shall be expressed as a percentage, with the total prescribed procedures, services, or medications within each classification of benefits as the denominator and the overall number of times prior authorization was required for any prescribed procedures, services, or medications within each corresponding classification of benefits as the numerator.</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;4(a)(2)">(2)</span> A description of the process used to develop and select medical necessity criteria for mental health condition and substance use disorder benefits;</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;4(a)(3)">(3)</span> An identification of all non-quantitative treatment limitations that are applied to benefits provided for mental health conditions and substance use disorders;</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;4(a)(4)">(4)</span> An analysis of the medical necessity criteria described in paragraph (2) of this subsection, and each non-quantitative treatment limitation identified pursuant to paragraph (3) of this subsection, that shall include:</p>
            <p class="text-indent-3"><span class="level-num" id="&#xA7;4(a)(4)(A)">(A)</span> An identification of the factors used to determine whether a non-quantitative treatment limitation shall apply to the provision of a benefit, including any factors that were considered but rejected;</p>
            <p class="text-indent-3"><span class="level-num" id="&#xA7;4(a)(4)(B)">(B)</span> An identification of the specific evidentiary standards that were relied upon and used to design any non-quantitative treatment limitations;</p>
            <p class="text-indent-3"><span class="level-num" id="&#xA7;4(a)(4)(C)">(C)</span> An identification and description of the methodology used to determine that the processes and strategies used to design each non-quantitative treatment limitation, as written, for mental health condition and substance use disorder benefits are comparable to and no more stringent than the processes and strategies used to design each non-quantitative treatment limitation, as written, for medical and surgical benefits;</p>
            <p class="text-indent-3"><span class="level-num" id="&#xA7;4(a)(4)(D)">(D)</span> An identification and description of the methodology used to determine that the processes and strategies used to apply each non-quantitative treatment limitation, in operation, for mental health condition and substance use disorder benefits are comparable to and no more stringent than the processes or strategies used to apply each non-quantitative treatment limitation, in operation, for medical and surgical benefits; and</p>
            <p class="text-indent-3"><span class="level-num" id="&#xA7;4(a)(4)(E)">(E)</span> A disclosure of the specific findings and conclusions reached by the health insurer indicating that it is in compliance with the requirements of <code-cite doc="D.C. Code" path="31|31E">this act</code-cite>.</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;4(a)(5)">(5)</span> The rates of, and reasons for, denial of claims for inpatient in-network, inpatient out-of-network, outpatient in-network, outpatient out-of-network, prescription drugs, and emergency care mental health condition and substance use disorder benefits during the prior calendar year, compared to the rates of and reasons for denial of claims in those same classifications of benefits for medical and surgical services during the prior calendar year;</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;4(a)(6)">(6)</span> A certification that the health insurer has completed a comprehensive review of the administrative practices of its health benefits plan for the prior calendar year to verify compliance with the requirements of <code-cite doc="D.C. Code" path="31|31E">this act</code-cite>; and</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;4(a)(7)">(7)</span> Any other information requested by the Commissioner of the Department.</p>
            <p class="text-indent-1"><span class="level-num" id="&#xA7;4(b)">(b)</span> By October 1, 2019, and annually thereafter, the Department shall issue a report to the Council in non-technical, readily understandable language, that shall:</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;4(b)(1)">(1)</span> Specify the methodologies used by the Department to verify compliance with the requirements of <code-cite doc="D.C. Code" path="31|31E">the act</code-cite>;</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;4(b)(2)">(2)</span> Identify the market conduct examinations conducted by the Department during the preceding year, including:</p>
            <p class="text-indent-3"><span class="level-num" id="&#xA7;4(b)(2)(A)">(A)</span> The number of market conduct examinations initiated and completed;</p>
            <p class="text-indent-3"><span class="level-num" id="&#xA7;4(b)(2)(B)">(B)</span> The benefit classifications assessed by each market conduct examination;</p>
            <p class="text-indent-3"><span class="level-num" id="&#xA7;4(b)(2)(C)">(C)</span> The subject matter of each market conduct examination; and</p>
            <p class="text-indent-3"><span class="level-num" id="&#xA7;4(b)(2)(D)">(D)</span> A summary of the basis for the final decision rendered in each market conduct examination;</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;4(b)(3)">(3)</span> A description of any educational or corrective actions the Department took to ensure health insurer compliance with the requirements of <code-cite doc="D.C. Code" path="31|31E">this act</code-cite>; and</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;4(b)(4)">(4)</span> A description of the Department's efforts to educate the public regarding mental health condition and substance use disorder protections under MHPAEA and <code-cite doc="D.C. Code" path="31|31E">this act</code-cite>.</p>
            <p class="marginalia">New <a href="/dc/council/code/sections/31-3175.04.html">§ 31-3175.04</a></p>
            <p id="&#xA7;5"><span class="level-num">Sec. 5. </span>Non-quantitative treatment limitations.</p>
            <p>A health insurer shall not impose a non-quantitative treatment limitation with respect to a mental health condition or substance use disorder for any classification of benefits unless, under the terms of the health benefits plan, as written and in operation, any processes, strategies, evidentiary standards or other factors used in applying the non-quantitative treatment limitation to mental health or substance use disorder benefits in the classification are comparable to, and are applied no more stringently than, the processes, strategies, evidentiary standards, or other factors used in applying the non-quantitative treatment limitation with respect to medical or surgical benefits in the same classification.</p>
            <p class="marginalia">New <a href="/dc/council/code/sections/31-3175.05.html">§ 31-3175.05</a></p>
            <p id="&#xA7;6"><span class="level-num">Sec. 6. </span>Medicaid coverage for medication-assisted treatment.</p>
            <p>Medicaid shall provide coverage for medication-assisted treatment prescribed for the treatment of substance use disorders; provided, that medication assisted treatment covered in accordance with this section shall not be subject to:</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;6(1)">(1)</span> Utilization control, other than those processes specified by the American Society of Addiction Medicine;</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;6(2)">(2)</span> Prior authorization;</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;6(3)">(3)</span> Step therapy; or</p>
            <p class="text-indent-2"><span class="level-num" id="&#xA7;6(4)">(4)</span> Lifetime restriction limits.</p>
            <p class="marginalia">New <a href="/dc/council/code/sections/31-3175.06.html">§ 31-3175.06</a></p>
            <p id="&#xA7;7"><span class="level-num">Sec. 7. </span>Rules.</p>
            <p>The Mayor, pursuant to <code-cite doc="D.C. Code" path="2|5|I">Title I of the District of Columbia Administrative Procedure Act, approved October 21, 1968 (82 Stat. 1204; D.C. Official Code § 2-501 <em>et seq</em>.)</code-cite>, may issue rules to implement the provisions of <code-cite doc="D.C. Code" path="31|31E">this act</code-cite>.</p>
            <p id="&#xA7;8"><span class="level-num">Sec. 8. </span>Fiscal impact statement.</p>
            <p>The Council adopts the fiscal impact statement in the committee report as the fiscal impact statement required by section 4a of the General Legislative Procedures Act of 1975, approved October 16, 2006 (120 Stat. 2038; D.C. Official Code § 1-301.47a).</p>
            <p id="&#xA7;9"><span class="level-num">Sec. 9. </span>Effective date.</p>
            <p>This act shall take effect following approval by the Mayor (or in the event of veto by the Mayor, action by the Council to override the veto), a 30-day period of congressional review as provided in section 602(c)(1) of the District of Columbia Home Rule Act, approved December 24, 1973 (87 Stat. 813; D.C. Official Code § 1-206.02(c)(1)), and publication in the District of Columbia Register.</p>
          </section>
        </section>
      </div>
    </main>
    <footer>
      <section class="container center">
        <p>The codes and laws on this website are in the public domain.</p>
        <p>
              Please do not scrape. Instead, bulk download the <a href="https://github.com/dccouncil/dc-law-html">HTML</a> or <a href="https://github.com/dccouncil/dc-law-xml">XML</a>.
            </p>
        <p>Powered by the non-profit <a href="http://www.openlawlib.org/">Open Law Library</a>.</p>
      </section>
    </footer>
    <script type="text/javascript" src="/js/main.js"> </script>
  </body>
</html>
